data_1dvw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dvw _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.509 ' HA ' ' CA ' ' A' ' 13' ' ' PRO . 17.7 m . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 121.148 0.499 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 22.5 p -146.58 60.81 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.98 -1.075 . . . . 0.0 110.989 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.32 28.53 0.72 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 9' ' ' CYS . . . -141.79 -55.8 0.46 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.597 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.654 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 7.9 p -137.26 32.61 0.2 Allowed Pre-proline 0 N--CA 1.496 1.852 0 C-N-CA 119.035 -1.066 . . . . 0.0 113.107 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 40.6 Cg_endo -67.55 -13.84 40.33 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 N-CA-C 105.967 -2.359 . . . . 0.0 105.967 175.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.48 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -89.22 -20.89 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 121.874 0.845 . . . . 0.0 109.753 179.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 12' ' ' CYS 0.268 0.9 OUTLIER -76.97 -67.1 0.74 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.368 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 16' ' ' VAL . 7.0 p -90.93 33.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 121.878 0.847 . . . . 0.0 110.748 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.529 ' HA ' ' CA ' ' A' ' 13' ' ' PRO . 17.8 m . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 121.248 0.547 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.534 ' SG ' ' CB ' ' A' ' 11' ' ' ALA . 14.0 p -146.89 62.13 1.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.2 -0.937 . . . . 0.0 110.704 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 47.24 27.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.534 ' CB ' ' SG ' ' A' ' 9' ' ' CYS . . . -141.39 -58.77 0.49 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.763 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.652 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.2 p -134.25 32.44 0.22 Allowed Pre-proline 0 N--CA 1.495 1.817 0 C-N-CA 118.92 -1.112 . . . . 0.0 113.395 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.3 Cg_endo -69.09 -14.7 38.71 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 N-CA-C 105.57 -2.511 . . . . 0.0 105.57 175.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -20.65 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 121.899 0.857 . . . . 0.0 109.56 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.504 HG23 ' CG2' ' A' ' 16' ' ' VAL 0.261 0.6 OUTLIER -88.46 -58.84 2.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.742 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.504 ' CG2' HG23 ' A' ' 15' ' ' THR . 43.1 t -91.08 31.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 8.0 pttt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.75 0.786 . . . . 0.0 110.979 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.445 ' O ' ' CG2' ' A' ' 8' ' ' THR . 8.3 m . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 121.181 0.515 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 18.8 p -145.67 60.97 1.27 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.113 -0.992 . . . . 0.0 110.768 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.44 28.15 0.7 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 9' ' ' CYS . . . -140.79 -60.03 0.51 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.807 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.658 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 10.2 p -130.73 30.8 0.2 Allowed Pre-proline 0 N--CA 1.497 1.885 0 C-N-CA 119.054 -1.058 . . . . 0.0 113.238 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 39.4 Cg_endo -67.28 -14.96 44.75 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 N-CA-C 105.718 -2.455 . . . . 0.0 105.718 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.434 ' O ' HG13 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -85.33 -20.72 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 121.895 0.855 . . . . 0.0 109.54 178.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.531 HG23 ' CG2' ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -84.91 -59.64 2.28 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.336 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.531 ' CG2' HG23 ' A' ' 15' ' ' THR . 4.2 t -91.14 36.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 17' ' ' LYS . 3.1 tmtm? . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.798 0.809 . . . . 0.0 110.979 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.179 0.514 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 11' ' ' ALA . 24.3 p -169.17 58.43 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.988 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.08 28.35 0.63 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' CB ' ' SG ' ' A' ' 9' ' ' CYS . . . -140.66 -55.88 0.51 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.665 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.64 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 7.3 p -137.53 34.86 0.24 Allowed Pre-proline 0 N--CA 1.496 1.83 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.995 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.7 Cg_endo -70.03 -13.23 33.75 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 N-CA-C 105.741 -2.446 . . . . 0.0 105.741 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.1 tt -90.28 -21.98 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.825 0.821 . . . . 0.0 109.742 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 12' ' ' CYS 0.269 0.9 OUTLIER -77.86 -67.02 0.77 Allowed 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.576 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.469 ' N ' ' CG2' ' A' ' 15' ' ' THR . 93.0 t -90.83 33.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 5.9 tttm . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.827 0.822 . . . . 0.0 110.588 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 78.6 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.137 0.494 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.53 ' SG ' ' CB ' ' A' ' 11' ' ' ALA . 13.3 p -152.99 60.48 0.78 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 0.0 110.874 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.01 27.73 0.54 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.53 ' CB ' ' SG ' ' A' ' 9' ' ' CYS . . . -138.61 -55.55 0.62 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.331 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.654 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.7 p -138.53 32.67 0.2 Allowed Pre-proline 0 N--CA 1.495 1.804 0 C-N-CA 119.086 -1.046 . . . . 0.0 113.048 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 41.5 Cg_endo -67.83 -16.12 45.3 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 N-CA-C 105.667 -2.474 . . . . 0.0 105.667 175.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 tp -91.67 -24.06 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 121.798 0.809 . . . . 0.0 110.303 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 16' ' ' VAL 0.259 0.8 OUTLIER -89.49 -60.73 1.87 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.526 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.515 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 70.3 t -90.46 36.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 tttt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.975 0.893 . . . . 0.0 110.466 -179.236 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.411 ' C ' ' SG ' ' A' ' 9' ' ' CYS . 23.9 m . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.394 0.616 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.479 ' C ' ' N ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -148.14 47.04 1.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.43 -0.794 . . . . 0.0 109.525 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 47.22 27.02 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.479 ' N ' ' C ' ' A' ' 9' ' ' CYS . . . -138.48 -53.43 0.61 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.425 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.67 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -129.55 27.92 0.15 Allowed Pre-proline 0 N--CA 1.498 1.965 0 C-N-CA 119.179 -1.009 . . . . 0.0 112.92 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 40.5 Cg_endo -67.5 -14.61 42.9 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 N-CA-C 105.891 -2.388 . . . . 0.0 105.891 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.88 -23.77 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 121.691 0.757 . . . . 0.0 110.302 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.429 HG21 HG13 ' A' ' 16' ' ' VAL 0.263 1.0 OUTLIER -70.38 -64.56 0.87 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.589 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.429 HG13 HG21 ' A' ' 15' ' ' THR . 32.2 m -90.82 32.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 122.144 0.973 . . . . 0.0 110.219 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 13' ' ' PRO . 4.2 m . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.222 0.534 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 11' ' ' ALA . 24.5 p -162.49 64.9 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.977 . . . . 0.0 110.899 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.55 27.68 0.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.531 ' CB ' ' SG ' ' A' ' 9' ' ' CYS . . . -142.17 -61.71 0.45 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.441 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 13.8 p -134.49 44.55 1.22 Allowed Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.092 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 46.6 Cg_endo -74.96 -9.33 20.78 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 N-CA-C 105.656 -2.479 . . . . 0.0 105.656 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.427 HG23 HD13 ' A' ' 14' ' ' ILE . 7.5 pt -90.0 -23.62 6.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.187 0.994 . . . . 0.0 109.139 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.514 ' CG2' ' N ' ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -73.26 -70.26 0.38 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.811 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 16' ' ' VAL . 53.5 t -90.82 31.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 5.6 tttt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.944 0.878 . . . . 0.0 110.519 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.469 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.9 m . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.068 0.461 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 21.0 p -153.6 61.89 0.74 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 0.0 111.028 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.03 28.64 0.65 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 9' ' ' CYS . . . -141.61 -53.83 0.45 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.377 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 8.6 p -141.44 37.41 0.26 Allowed Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.857 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.4 Cg_endo -69.77 -12.89 33.8 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 105.83 -2.411 . . . . 0.0 105.83 175.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 tp -87.65 -22.3 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 122.002 0.906 . . . . 0.0 109.455 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 12' ' ' CYS 0.273 0.9 OUTLIER -83.75 -59.56 2.39 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.322 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 16' ' ' VAL . 14.7 p -90.93 37.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 2.8 tttt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 121.676 0.751 . . . . 0.0 111.223 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.501 ' HA ' ' CA ' ' A' ' 13' ' ' PRO . 17.6 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.155 0.502 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 11' ' ' ALA . 20.8 p -157.18 62.46 0.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.961 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.16 28.01 0.61 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.536 ' CB ' ' SG ' ' A' ' 9' ' ' CYS . . . -140.56 -55.22 0.51 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.147 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.634 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 12.7 p -140.26 35.65 0.23 Allowed Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.873 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 41.5 Cg_endo -68.54 -14.61 40.07 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 N-CA-C 105.703 -2.46 . . . . 0.0 105.703 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 15' ' ' THR . 2.3 tp -90.5 -25.48 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-O 122.04 0.924 . . . . 0.0 109.314 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.479 ' CG2' ' N ' ' A' ' 16' ' ' VAL 0.264 0.8 OUTLIER -91.3 -63.22 1.29 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.272 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.479 ' N ' ' CG2' ' A' ' 15' ' ' THR . 58.2 t -90.2 37.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.881 0.848 . . . . 0.0 110.476 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.519 ' HA ' ' CA ' ' A' ' 13' ' ' PRO . 3.4 m . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.168 0.508 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.534 ' SG ' ' CB ' ' A' ' 11' ' ' ALA . 19.4 p -147.72 61.93 1.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.7 27.94 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.534 ' CB ' ' SG ' ' A' ' 9' ' ' CYS . . . -140.99 -59.15 0.5 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.815 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.64 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.0 p -134.58 35.47 0.28 Allowed Pre-proline 0 N--CA 1.496 1.849 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.844 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.2 Cg_endo -69.43 -12.46 33.56 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 N-CA-C 105.913 -2.38 . . . . 0.0 105.913 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.7 pt -90.66 -22.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 122.041 0.924 . . . . 0.0 109.509 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.504 ' CG2' ' N ' ' A' ' 16' ' ' VAL 0.266 0.8 OUTLIER -88.92 -63.47 1.29 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.112 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 15' ' ' THR . 76.0 t -90.27 40.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 23.7 tttm . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.638 0.733 . . . . 0.0 110.864 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.517 ' O ' ' CG2' ' A' ' 1' ' ' THR . 8.9 t . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.239 0.542 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 56.4 mt 50.65 -141.86 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 110.131 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.437 ' HB2' ' HE1' ' A' ' 7' ' ' MET . . . -56.72 152.92 11.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 110.29 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.489 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 25.4 m -140.79 166.26 24.03 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.825 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 43.4 Cg_endo -70.26 85.3 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.803 1.423 . . . . 0.0 110.384 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 7' ' ' MET . . . 154.9 -60.31 0.38 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.468 ' CB ' HG12 ' A' ' 16' ' ' VAL . 0.6 OUTLIER 56.55 -161.89 0.19 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.339 -1.095 . . . . 0.0 109.894 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.509 ' HA ' ' CA ' ' A' ' 13' ' ' PRO . 17.7 m 54.1 69.76 0.68 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.18 -0.95 . . . . 0.0 110.267 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 22.5 p -146.58 60.81 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.98 -1.075 . . . . 0.0 110.989 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.32 28.53 0.72 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 9' ' ' CYS . . . -141.79 -55.8 0.46 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.597 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.654 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 7.9 p -137.26 32.61 0.2 Allowed Pre-proline 0 N--CA 1.496 1.852 0 C-N-CA 119.035 -1.066 . . . . 0.0 113.107 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 40.6 Cg_endo -67.55 -13.84 40.33 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 N-CA-C 105.967 -2.359 . . . . 0.0 105.967 175.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.48 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -89.22 -20.89 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 121.874 0.845 . . . . 0.0 109.753 179.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 12' ' ' CYS 0.268 0.9 OUTLIER -76.97 -67.1 0.74 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.368 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.468 HG12 ' CB ' ' A' ' 7' ' ' MET . 7.0 p -90.93 33.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -56.58 -15.03 3.66 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.878 0.847 . . . . 0.0 110.748 -179.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.2 tptp . . . . . 0 C--N 1.29 -1.993 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.163 179.979 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.309 0.576 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 mp -119.73 38.08 4.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.212 -0.93 . . . . 0.0 110.248 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.1 117.18 31.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.044 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.459 HG12 ' HD2' ' A' ' 5' ' ' PRO . 84.4 t -94.83 133.08 27.11 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.967 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' HD2' HG12 ' A' ' 4' ' ' VAL . 44.2 Cg_endo -70.74 120.83 7.38 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.95 1.5 . . . . 0.0 110.616 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' MET . . . 119.28 -31.44 5.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.462 ' O ' ' HB ' ' A' ' 8' ' ' THR . 3.2 mmt 46.28 -159.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -1.178 . . . . 0.0 109.155 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.529 ' HA ' ' CA ' ' A' ' 13' ' ' PRO . 17.8 m 53.98 82.25 0.09 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.885 -1.134 . . . . 0.0 109.732 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.534 ' SG ' ' CB ' ' A' ' 11' ' ' ALA . 14.0 p -146.89 62.13 1.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.2 -0.937 . . . . 0.0 110.704 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 47.24 27.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.534 ' CB ' ' SG ' ' A' ' 9' ' ' CYS . . . -141.39 -58.77 0.49 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.763 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.652 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.2 p -134.25 32.44 0.22 Allowed Pre-proline 0 N--CA 1.495 1.817 0 C-N-CA 118.92 -1.112 . . . . 0.0 113.395 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.3 Cg_endo -69.09 -14.7 38.71 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 N-CA-C 105.57 -2.511 . . . . 0.0 105.57 175.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -20.65 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 121.899 0.857 . . . . 0.0 109.56 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.504 HG23 ' CG2' ' A' ' 16' ' ' VAL 0.261 0.6 OUTLIER -88.46 -58.84 2.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.742 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.504 ' CG2' HG23 ' A' ' 15' ' ' THR . 43.1 t -91.08 31.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 8.0 pttt -56.34 -14.77 3.16 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.75 0.786 . . . . 0.0 110.979 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.29 -2.011 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.058 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.227 0.537 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.8 81.01 1.36 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.254 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.87 142.67 6.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.264 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 4' ' ' VAL . 12.4 p -58.66 135.84 86.36 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 110.005 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HD2' HG21 ' A' ' 4' ' ' VAL . 44.9 Cg_endo -72.24 115.26 4.25 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.967 1.509 . . . . 0.0 110.364 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.42 -29.47 7.58 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.463 ' O ' ' HB ' ' A' ' 8' ' ' THR . 0.0 OUTLIER 51.53 -164.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -1.155 . . . . 0.0 109.54 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 7' ' ' MET . 8.3 m 54.07 75.33 0.28 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.128 -0.982 . . . . 0.0 110.049 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 18.8 p -145.67 60.97 1.27 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.113 -0.992 . . . . 0.0 110.768 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.44 28.15 0.7 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 9' ' ' CYS . . . -140.79 -60.03 0.51 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.807 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.658 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 10.2 p -130.73 30.8 0.2 Allowed Pre-proline 0 N--CA 1.497 1.885 0 C-N-CA 119.054 -1.058 . . . . 0.0 113.238 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 39.4 Cg_endo -67.28 -14.96 44.75 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 N-CA-C 105.718 -2.455 . . . . 0.0 105.718 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.434 ' O ' HG13 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -85.33 -20.72 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 121.895 0.855 . . . . 0.0 109.54 178.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.531 HG23 ' CG2' ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -84.91 -59.64 2.28 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.336 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.531 ' CG2' HG23 ' A' ' 15' ' ' THR . 4.2 t -91.14 36.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 17' ' ' LYS . 3.1 tmtm? -59.84 -11.51 5.56 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.798 0.809 . . . . 0.0 110.979 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 mptt . . . . . 0 C--N 1.284 -2.249 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.322 179.744 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.201 0.524 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.458 ' O ' ' CG2' ' A' ' 15' ' ' THR . 0.1 OUTLIER -52.54 -37.82 58.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.942 . . . . 0.0 110.01 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.71 132.49 52.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.317 -0.864 . . . . 0.0 109.982 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.514 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 2.7 m -124.38 168.32 13.33 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.3 -0.875 . . . . 0.0 109.743 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 41.2 Cg_endo -68.35 65.94 1.09 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.741 1.39 . . . . 0.0 109.721 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.66 174.74 17.19 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.447 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -146.88 127.64 14.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.076 -1.249 . . . . 0.0 110.383 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 m 53.03 92.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.396 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 11' ' ' ALA . 24.3 p -169.17 58.43 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.988 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.08 28.35 0.63 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' CB ' ' SG ' ' A' ' 9' ' ' CYS . . . -140.66 -55.88 0.51 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.665 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.64 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 7.3 p -137.53 34.86 0.24 Allowed Pre-proline 0 N--CA 1.496 1.83 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.995 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.7 Cg_endo -70.03 -13.23 33.75 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 N-CA-C 105.741 -2.446 . . . . 0.0 105.741 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.1 tt -90.28 -21.98 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.825 0.821 . . . . 0.0 109.742 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 12' ' ' CYS 0.269 0.9 OUTLIER -77.86 -67.02 0.77 Allowed 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.576 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.469 ' N ' ' CG2' ' A' ' 15' ' ' THR . 93.0 t -90.83 33.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 5.9 tttm -55.14 -16.89 3.46 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.827 0.822 . . . . 0.0 110.588 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt . . . . . 0 C--N 1.289 -2.033 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.183 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 54.1 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.237 0.542 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.0 mt -92.85 71.09 4.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 110.203 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.07 105.42 14.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 110.182 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.494 ' CG2' ' HB2' ' A' ' 7' ' ' MET . 17.6 m -126.33 165.51 27.43 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.747 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 43.0 Cg_endo -69.44 67.71 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.819 1.431 . . . . 0.0 109.919 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 12' ' ' CYS . . . 161.56 -25.78 0.25 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.494 ' HB2' ' CG2' ' A' ' 4' ' ' VAL . 6.5 mtt -126.99 120.69 29.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -1.122 . . . . 0.0 110.472 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 78.6 m 54.2 78.55 0.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.863 . . . . 0.0 110.779 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.53 ' SG ' ' CB ' ' A' ' 11' ' ' ALA . 13.3 p -152.99 60.48 0.78 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 0.0 110.874 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.01 27.73 0.54 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.53 ' CB ' ' SG ' ' A' ' 9' ' ' CYS . . . -138.61 -55.55 0.62 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.331 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.654 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.7 p -138.53 32.67 0.2 Allowed Pre-proline 0 N--CA 1.495 1.804 0 C-N-CA 119.086 -1.046 . . . . 0.0 113.048 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 41.5 Cg_endo -67.83 -16.12 45.3 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 N-CA-C 105.667 -2.474 . . . . 0.0 105.667 175.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 tp -91.67 -24.06 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 121.798 0.809 . . . . 0.0 110.303 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 16' ' ' VAL 0.259 0.8 OUTLIER -89.49 -60.73 1.87 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.526 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.515 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 70.3 t -90.46 36.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -54.5 -17.79 3.59 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.975 0.893 . . . . 0.0 110.466 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.29 -1.983 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.069 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.29 0.567 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.78 115.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.316 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.73 75.07 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 110.038 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.3 t -83.4 123.6 76.67 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 110.059 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.67 107.29 2.15 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.884 1.465 . . . . 0.0 110.348 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' MET . . . 126.0 -27.99 4.98 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.486 ' O ' ' HB ' ' A' ' 8' ' ' THR . 48.2 mmm 60.58 -138.77 0.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -1.12 . . . . 0.0 109.827 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 7' ' ' MET . 23.9 m 60.66 76.67 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.354 -0.842 . . . . 0.0 109.642 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.479 ' C ' ' N ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -148.14 47.04 1.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.43 -0.794 . . . . 0.0 109.525 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 47.22 27.02 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.479 ' N ' ' C ' ' A' ' 9' ' ' CYS . . . -138.48 -53.43 0.61 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.425 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.67 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -129.55 27.92 0.15 Allowed Pre-proline 0 N--CA 1.498 1.965 0 C-N-CA 119.179 -1.009 . . . . 0.0 112.92 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 40.5 Cg_endo -67.5 -14.61 42.9 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 N-CA-C 105.891 -2.388 . . . . 0.0 105.891 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.88 -23.77 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 121.691 0.757 . . . . 0.0 110.302 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.429 HG21 HG13 ' A' ' 16' ' ' VAL 0.263 1.0 OUTLIER -70.38 -64.56 0.87 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.589 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.429 HG13 HG21 ' A' ' 15' ' ' THR . 32.2 m -90.82 32.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -48.92 -23.02 0.96 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 122.144 0.973 . . . . 0.0 110.219 -179.033 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.287 -2.125 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.258 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 2' ' ' LEU . 2.2 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.181 0.515 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 1' ' ' THR . 1.1 tt -45.41 115.23 0.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.952 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.71 177.87 4.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 110.39 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.487 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 3.4 m -98.87 166.49 13.01 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.856 . . . . 0.0 110.042 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 45.3 Cg_endo -72.92 76.36 2.52 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.921 1.485 . . . . 0.0 110.331 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.44 -119.8 1.12 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -169.42 -165.53 0.53 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.259 -1.142 . . . . 0.0 109.957 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 7' ' ' MET . 4.2 m 49.18 97.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.07 -1.019 . . . . 0.0 110.055 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 11' ' ' ALA . 24.5 p -162.49 64.9 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.977 . . . . 0.0 110.899 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.55 27.68 0.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.531 ' CB ' ' SG ' ' A' ' 9' ' ' CYS . . . -142.17 -61.71 0.45 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.441 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 13.8 p -134.49 44.55 1.22 Allowed Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.092 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 46.6 Cg_endo -74.96 -9.33 20.78 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 N-CA-C 105.656 -2.479 . . . . 0.0 105.656 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.427 HG23 HD13 ' A' ' 14' ' ' ILE . 7.5 pt -90.0 -23.62 6.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.187 0.994 . . . . 0.0 109.139 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.514 ' CG2' ' N ' ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -73.26 -70.26 0.38 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.811 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 16' ' ' VAL . 53.5 t -90.82 31.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 5.6 tttt -52.04 -19.38 1.84 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.944 0.878 . . . . 0.0 110.519 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.4 pttp . . . . . 0 C--N 1.288 -2.07 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.22 -179.902 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.252 0.549 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.406 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 1.1 mp 56.17 -178.6 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.204 -0.935 . . . . 0.0 110.243 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 2' ' ' LEU . . . 63.18 50.78 2.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 110.434 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.437 ' CG2' ' HD2' ' A' ' 5' ' ' PRO . 11.4 p -143.22 142.83 22.44 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.13 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.437 ' HD2' ' CG2' ' A' ' 4' ' ' VAL . 47.6 Cg_endo -73.35 149.2 44.67 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.015 1.534 . . . . 0.0 110.36 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.36 -27.88 8.08 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.522 ' CB ' HG13 ' A' ' 16' ' ' VAL . 9.1 mtm 52.59 -157.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -1.166 . . . . 0.0 109.731 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.469 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.9 m 52.32 81.7 0.08 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.093 -1.005 . . . . 0.0 109.992 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 11' ' ' ALA . 21.0 p -153.6 61.89 0.74 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 0.0 111.028 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.03 28.64 0.65 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.536 ' CB ' ' SG ' ' A' ' 9' ' ' CYS . . . -141.61 -53.83 0.45 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.377 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 8.6 p -141.44 37.41 0.26 Allowed Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.857 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.4 Cg_endo -69.77 -12.89 33.8 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 105.83 -2.411 . . . . 0.0 105.83 175.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 tp -87.65 -22.3 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 122.002 0.906 . . . . 0.0 109.455 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 12' ' ' CYS 0.273 0.9 OUTLIER -83.75 -59.56 2.39 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.322 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.522 HG13 ' CB ' ' A' ' 7' ' ' MET . 14.7 p -90.93 37.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 2.8 tttt -66.09 -4.68 7.83 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.676 0.751 . . . . 0.0 111.223 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.034 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.223 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.274 0.559 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.96 36.73 4.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 0.0 110.261 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.9 100.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 110.142 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.486 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 27.6 m -102.59 165.8 13.1 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.831 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.486 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 40.9 Cg_endo -67.62 59.76 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.783 1.412 . . . . 0.0 109.946 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 7' ' ' MET . . . 153.72 -150.95 22.74 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.463 ' HB3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER 176.74 122.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -1.216 . . . . 0.0 109.895 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.501 ' HA ' ' CA ' ' A' ' 13' ' ' PRO . 17.6 m 44.46 83.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.111 -0.993 . . . . 0.0 110.303 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 11' ' ' ALA . 20.8 p -157.18 62.46 0.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.961 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.16 28.01 0.61 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.536 ' CB ' ' SG ' ' A' ' 9' ' ' CYS . . . -140.56 -55.22 0.51 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.147 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.634 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 12.7 p -140.26 35.65 0.23 Allowed Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.873 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 41.5 Cg_endo -68.54 -14.61 40.07 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 N-CA-C 105.703 -2.46 . . . . 0.0 105.703 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 15' ' ' THR . 2.3 tp -90.5 -25.48 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-O 122.04 0.924 . . . . 0.0 109.314 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.479 ' CG2' ' N ' ' A' ' 16' ' ' VAL 0.264 0.8 OUTLIER -91.3 -63.22 1.29 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.272 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.479 ' N ' ' CG2' ' A' ' 15' ' ' THR . 58.2 t -90.2 37.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -56.03 -16.51 5.05 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.881 0.848 . . . . 0.0 110.476 -179.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.4 tptm . . . . . 0 C--N 1.289 -2.027 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.189 179.809 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.249 0.547 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.6 mt -128.33 133.29 48.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 110.217 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.21 108.94 2.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.2 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 23.2 m -57.7 163.77 3.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.218 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 45.9 Cg_endo -73.1 123.07 8.57 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.974 1.512 . . . . 0.0 110.456 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 7' ' ' MET . . . 115.96 -27.23 8.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.514 ' HG2' ' CG2' ' A' ' 16' ' ' VAL . 0.0 OUTLIER 56.31 -156.92 0.27 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -1.101 . . . . 0.0 109.991 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.519 ' HA ' ' CA ' ' A' ' 13' ' ' PRO . 3.4 m 55.09 78.55 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.103 -0.998 . . . . 0.0 110.038 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.534 ' SG ' ' CB ' ' A' ' 11' ' ' ALA . 19.4 p -147.72 61.93 1.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.7 27.94 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.534 ' CB ' ' SG ' ' A' ' 9' ' ' CYS . . . -140.99 -59.15 0.5 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.815 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.64 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.0 p -134.58 35.47 0.28 Allowed Pre-proline 0 N--CA 1.496 1.849 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.844 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.2 Cg_endo -69.43 -12.46 33.56 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 N-CA-C 105.913 -2.38 . . . . 0.0 105.913 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.7 pt -90.66 -22.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 122.041 0.924 . . . . 0.0 109.509 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.504 ' CG2' ' N ' ' A' ' 16' ' ' VAL 0.266 0.8 OUTLIER -88.92 -63.47 1.29 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.112 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.514 ' CG2' ' HG2' ' A' ' 7' ' ' MET . 76.0 t -90.27 40.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 23.7 tttm -66.53 -5.81 12.68 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.638 0.733 . . . . 0.0 110.864 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.289 -2.032 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.275 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.727 ' O ' HG22 ' A' ' 8' ' ' THR . 17.7 m . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 121.148 0.499 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.927 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 22.5 p -146.58 60.81 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.98 -1.075 . . . . 0.0 110.989 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.32 28.53 0.72 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.927 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -141.79 -55.8 0.46 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.597 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.654 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 7.9 p -137.26 32.61 0.2 Allowed Pre-proline 0 N--CA 1.496 1.852 0 C-N-CA 119.035 -1.066 . . . . 0.0 113.107 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 40.6 Cg_endo -67.55 -13.84 40.33 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 N-CA-C 105.967 -2.359 . . . . 0.0 105.967 175.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.545 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -89.22 -20.89 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 121.874 0.845 . . . . 0.0 109.753 179.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.673 HG22 ' N ' ' A' ' 16' ' ' VAL 0.268 0.9 OUTLIER -76.97 -67.1 0.74 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.368 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.673 ' N ' HG22 ' A' ' 15' ' ' THR . 7.0 p -90.93 33.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.545 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 121.878 0.847 . . . . 0.0 110.748 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.706 HG23 ' HB3' ' A' ' 13' ' ' PRO . 17.8 m . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 121.248 0.547 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.904 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 14.0 p -146.89 62.13 1.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.2 -0.937 . . . . 0.0 110.704 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 47.24 27.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.904 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -141.39 -58.77 0.49 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.763 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.652 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.2 p -134.25 32.44 0.22 Allowed Pre-proline 0 N--CA 1.495 1.817 0 C-N-CA 118.92 -1.112 . . . . 0.0 113.395 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.706 ' HB3' HG23 ' A' ' 8' ' ' THR . 42.3 Cg_endo -69.09 -14.7 38.71 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 N-CA-C 105.57 -2.511 . . . . 0.0 105.57 175.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -20.65 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 121.899 0.857 . . . . 0.0 109.56 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 1.0 HG22 HG23 ' A' ' 16' ' ' VAL 0.261 0.6 OUTLIER -88.46 -58.84 2.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.742 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.0 HG23 HG22 ' A' ' 15' ' ' THR . 43.1 t -91.08 31.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 8.0 pttt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.75 0.786 . . . . 0.0 110.979 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.692 ' O ' HG22 ' A' ' 8' ' ' THR . 8.3 m . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 121.181 0.515 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.92 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 18.8 p -145.67 60.97 1.27 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.113 -0.992 . . . . 0.0 110.768 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.44 28.15 0.7 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.92 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.79 -60.03 0.51 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.807 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.658 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 10.2 p -130.73 30.8 0.2 Allowed Pre-proline 0 N--CA 1.497 1.885 0 C-N-CA 119.054 -1.058 . . . . 0.0 113.238 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 39.4 Cg_endo -67.28 -14.96 44.75 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 N-CA-C 105.718 -2.455 . . . . 0.0 105.718 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.455 HG22 ' H ' ' A' ' 14' ' ' ILE . 0.3 OUTLIER -85.33 -20.72 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 121.895 0.855 . . . . 0.0 109.54 178.716 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.839 HG22 HG23 ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -84.91 -59.64 2.28 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.336 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.839 HG23 HG22 ' A' ' 15' ' ' THR . 4.2 t -91.14 36.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 17' ' ' LYS . 3.1 tmtm? . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.798 0.809 . . . . 0.0 110.979 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.179 0.514 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.944 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 24.3 p -169.17 58.43 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.988 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.08 28.35 0.63 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.944 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.66 -55.88 0.51 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.665 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.64 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 7.3 p -137.53 34.86 0.24 Allowed Pre-proline 0 N--CA 1.496 1.83 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.995 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.7 Cg_endo -70.03 -13.23 33.75 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 N-CA-C 105.741 -2.446 . . . . 0.0 105.741 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.48 HG22 ' H ' ' A' ' 14' ' ' ILE . 1.1 tt -90.28 -21.98 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.825 0.821 . . . . 0.0 109.742 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.962 HG22 HG23 ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -77.86 -67.02 0.77 Allowed 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.576 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.962 HG23 HG22 ' A' ' 15' ' ' THR . 93.0 t -90.83 33.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 5.9 tttm . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.827 0.822 . . . . 0.0 110.588 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 78.6 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.137 0.494 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.904 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 13.3 p -152.99 60.48 0.78 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 0.0 110.874 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.01 27.73 0.54 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.904 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -138.61 -55.55 0.62 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.331 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.654 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.7 p -138.53 32.67 0.2 Allowed Pre-proline 0 N--CA 1.495 1.804 0 C-N-CA 119.086 -1.046 . . . . 0.0 113.048 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 41.5 Cg_endo -67.83 -16.12 45.3 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 N-CA-C 105.667 -2.474 . . . . 0.0 105.667 175.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 tp -91.67 -24.06 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 121.798 0.809 . . . . 0.0 110.303 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.855 HG22 HG23 ' A' ' 16' ' ' VAL 0.259 0.8 OUTLIER -89.49 -60.73 1.87 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.526 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.855 HG23 HG22 ' A' ' 15' ' ' THR . 70.3 t -90.46 36.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 tttt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.975 0.893 . . . . 0.0 110.466 -179.236 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.411 ' C ' ' SG ' ' A' ' 9' ' ' CYS . 23.9 m . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.394 0.616 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.479 ' C ' ' N ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -148.14 47.04 1.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.43 -0.794 . . . . 0.0 109.525 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 47.22 27.02 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.496 ' H ' ' HD3' ' A' ' 13' ' ' PRO . . . -138.48 -53.43 0.61 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.425 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.67 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -129.55 27.92 0.15 Allowed Pre-proline 0 N--CA 1.498 1.965 0 C-N-CA 119.179 -1.009 . . . . 0.0 112.92 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 40.5 Cg_endo -67.5 -14.61 42.9 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 N-CA-C 105.891 -2.388 . . . . 0.0 105.891 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.478 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -90.88 -23.77 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 121.691 0.757 . . . . 0.0 110.302 179.276 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.906 HG22 HG13 ' A' ' 16' ' ' VAL 0.263 1.0 OUTLIER -70.38 -64.56 0.87 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.589 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.906 HG13 HG22 ' A' ' 15' ' ' THR . 32.2 m -90.82 32.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.478 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 122.144 0.973 . . . . 0.0 110.219 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 13' ' ' PRO . 4.2 m . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.222 0.534 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.876 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 24.5 p -162.49 64.9 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.977 . . . . 0.0 110.899 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.55 27.68 0.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.876 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -142.17 -61.71 0.45 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.441 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 13.8 p -134.49 44.55 1.22 Allowed Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.092 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 46.6 Cg_endo -74.96 -9.33 20.78 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 N-CA-C 105.656 -2.479 . . . . 0.0 105.656 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 7.5 pt -90.0 -23.62 6.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.187 0.994 . . . . 0.0 109.139 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.816 HG22 HG23 ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -73.26 -70.26 0.38 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.811 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.816 HG23 HG22 ' A' ' 15' ' ' THR . 53.5 t -90.82 31.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 5.6 tttt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.944 0.878 . . . . 0.0 110.519 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.761 ' O ' HG22 ' A' ' 8' ' ' THR . 1.9 m . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.068 0.461 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.907 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 21.0 p -153.6 61.89 0.74 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 0.0 111.028 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.03 28.64 0.65 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.907 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -141.61 -53.83 0.45 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.377 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 8.6 p -141.44 37.41 0.26 Allowed Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.857 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.4 Cg_endo -69.77 -12.89 33.8 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 105.83 -2.411 . . . . 0.0 105.83 175.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 2.0 tp -87.65 -22.3 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 122.002 0.906 . . . . 0.0 109.455 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.601 HG22 ' N ' ' A' ' 16' ' ' VAL 0.273 0.9 OUTLIER -83.75 -59.56 2.39 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.322 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.601 ' N ' HG22 ' A' ' 15' ' ' THR . 14.7 p -90.93 37.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.468 ' CA ' ' O ' ' A' ' 13' ' ' PRO . 2.8 tttt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 121.676 0.751 . . . . 0.0 111.223 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.55 ' O ' HG22 ' A' ' 8' ' ' THR . 17.6 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.155 0.502 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.899 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 20.8 p -157.18 62.46 0.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.961 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.16 28.01 0.61 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.899 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.56 -55.22 0.51 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.147 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.634 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 12.7 p -140.26 35.65 0.23 Allowed Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.873 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 41.5 Cg_endo -68.54 -14.61 40.07 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 N-CA-C 105.703 -2.46 . . . . 0.0 105.703 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 tp -90.5 -25.48 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-O 122.04 0.924 . . . . 0.0 109.314 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 1.016 HG22 HG23 ' A' ' 16' ' ' VAL 0.264 0.8 OUTLIER -91.3 -63.22 1.29 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.272 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.016 HG23 HG22 ' A' ' 15' ' ' THR . 58.2 t -90.2 37.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.881 0.848 . . . . 0.0 110.476 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.723 ' O ' HG22 ' A' ' 8' ' ' THR . 3.4 m . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.168 0.508 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.908 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 19.4 p -147.72 61.93 1.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.7 27.94 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.908 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.99 -59.15 0.5 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.815 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.64 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.0 p -134.58 35.47 0.28 Allowed Pre-proline 0 N--CA 1.496 1.849 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.844 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.2 Cg_endo -69.43 -12.46 33.56 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 N-CA-C 105.913 -2.38 . . . . 0.0 105.913 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.7 pt -90.66 -22.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 122.041 0.924 . . . . 0.0 109.509 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.872 HG22 HG23 ' A' ' 16' ' ' VAL 0.266 0.8 OUTLIER -88.92 -63.47 1.29 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.112 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.872 HG23 HG22 ' A' ' 15' ' ' THR . 76.0 t -90.27 40.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 23.7 tttm . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.638 0.733 . . . . 0.0 110.864 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.74 ' O ' HG23 ' A' ' 1' ' ' THR . 8.9 t . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.239 0.542 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 56.4 mt 50.65 -141.86 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 110.131 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.72 152.92 11.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 110.29 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.496 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 25.4 m -140.79 166.26 24.03 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.825 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 43.4 Cg_endo -70.26 85.3 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.803 1.423 . . . . 0.0 110.384 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 7' ' ' MET . . . 154.9 -60.31 0.38 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.577 ' CB ' HG11 ' A' ' 16' ' ' VAL . 0.6 OUTLIER 56.55 -161.89 0.19 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.339 -1.095 . . . . 0.0 109.894 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.727 ' O ' HG22 ' A' ' 8' ' ' THR . 17.7 m 54.1 69.76 0.68 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.18 -0.95 . . . . 0.0 110.267 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.927 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 22.5 p -146.58 60.81 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.98 -1.075 . . . . 0.0 110.989 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.32 28.53 0.72 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.927 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -141.79 -55.8 0.46 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.597 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.654 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 7.9 p -137.26 32.61 0.2 Allowed Pre-proline 0 N--CA 1.496 1.852 0 C-N-CA 119.035 -1.066 . . . . 0.0 113.107 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 40.6 Cg_endo -67.55 -13.84 40.33 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 N-CA-C 105.967 -2.359 . . . . 0.0 105.967 175.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.545 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -89.22 -20.89 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 121.874 0.845 . . . . 0.0 109.753 179.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.673 HG22 ' N ' ' A' ' 16' ' ' VAL 0.268 0.9 OUTLIER -76.97 -67.1 0.74 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.368 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.673 ' N ' HG22 ' A' ' 15' ' ' THR . 7.0 p -90.93 33.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.545 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -56.58 -15.03 3.66 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.878 0.847 . . . . 0.0 110.748 -179.031 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.2 tptp . . . . . 0 C--N 1.29 -1.993 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.163 179.979 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.309 0.576 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 mp -119.73 38.08 4.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.212 -0.93 . . . . 0.0 110.248 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.1 117.18 31.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.044 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.4 t -94.83 133.08 27.11 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.967 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.74 120.83 7.38 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.95 1.5 . . . . 0.0 110.616 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' MET . . . 119.28 -31.44 5.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.664 ' SD ' HG21 ' A' ' 16' ' ' VAL . 3.2 mmt 46.28 -159.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -1.178 . . . . 0.0 109.155 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.706 HG23 ' HB3' ' A' ' 13' ' ' PRO . 17.8 m 53.98 82.25 0.09 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.885 -1.134 . . . . 0.0 109.732 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.904 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 14.0 p -146.89 62.13 1.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.2 -0.937 . . . . 0.0 110.704 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 47.24 27.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.904 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -141.39 -58.77 0.49 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.763 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.652 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.2 p -134.25 32.44 0.22 Allowed Pre-proline 0 N--CA 1.495 1.817 0 C-N-CA 118.92 -1.112 . . . . 0.0 113.395 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.706 ' HB3' HG23 ' A' ' 8' ' ' THR . 42.3 Cg_endo -69.09 -14.7 38.71 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 N-CA-C 105.57 -2.511 . . . . 0.0 105.57 175.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -20.65 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 121.899 0.857 . . . . 0.0 109.56 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 1.0 HG22 HG23 ' A' ' 16' ' ' VAL 0.261 0.6 OUTLIER -88.46 -58.84 2.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.742 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.0 HG23 HG22 ' A' ' 15' ' ' THR . 43.1 t -91.08 31.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 8.0 pttt -56.34 -14.77 3.16 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.75 0.786 . . . . 0.0 110.979 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.29 -2.011 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.058 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.227 0.537 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.8 81.01 1.36 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.254 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.87 142.67 6.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.264 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 4' ' ' VAL . 12.4 p -58.66 135.84 86.36 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 110.005 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.24 115.26 4.25 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.967 1.509 . . . . 0.0 110.364 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.42 -29.47 7.58 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.528 ' CG ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER 51.53 -164.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -1.155 . . . . 0.0 109.54 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.692 ' O ' HG22 ' A' ' 8' ' ' THR . 8.3 m 54.07 75.33 0.28 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.128 -0.982 . . . . 0.0 110.049 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.92 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 18.8 p -145.67 60.97 1.27 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.113 -0.992 . . . . 0.0 110.768 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.44 28.15 0.7 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.92 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.79 -60.03 0.51 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.807 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.658 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 10.2 p -130.73 30.8 0.2 Allowed Pre-proline 0 N--CA 1.497 1.885 0 C-N-CA 119.054 -1.058 . . . . 0.0 113.238 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 39.4 Cg_endo -67.28 -14.96 44.75 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 N-CA-C 105.718 -2.455 . . . . 0.0 105.718 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.455 HG22 ' H ' ' A' ' 14' ' ' ILE . 0.3 OUTLIER -85.33 -20.72 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 121.895 0.855 . . . . 0.0 109.54 178.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.839 HG22 HG23 ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -84.91 -59.64 2.28 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.336 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.839 HG23 HG22 ' A' ' 15' ' ' THR . 4.2 t -91.14 36.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 17' ' ' LYS . 3.1 tmtm? -59.84 -11.51 5.56 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.798 0.809 . . . . 0.0 110.979 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 mptt . . . . . 0 C--N 1.284 -2.249 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.322 179.744 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.201 0.524 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.581 ' O ' HG23 ' A' ' 15' ' ' THR . 0.1 OUTLIER -52.54 -37.82 58.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.942 . . . . 0.0 110.01 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.71 132.49 52.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.317 -0.864 . . . . 0.0 109.982 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.538 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 2.7 m -124.38 168.32 13.33 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.3 -0.875 . . . . 0.0 109.743 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.538 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 41.2 Cg_endo -68.35 65.94 1.09 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.741 1.39 . . . . 0.0 109.721 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 4' ' ' VAL . . . 144.66 174.74 17.19 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.487 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -146.88 127.64 14.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.076 -1.249 . . . . 0.0 110.383 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 m 53.03 92.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.396 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.944 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 24.3 p -169.17 58.43 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.988 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.08 28.35 0.63 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.944 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.66 -55.88 0.51 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.665 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.64 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 7.3 p -137.53 34.86 0.24 Allowed Pre-proline 0 N--CA 1.496 1.83 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.995 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.7 Cg_endo -70.03 -13.23 33.75 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 N-CA-C 105.741 -2.446 . . . . 0.0 105.741 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.48 HG22 ' H ' ' A' ' 14' ' ' ILE . 1.1 tt -90.28 -21.98 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.825 0.821 . . . . 0.0 109.742 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.962 HG22 HG23 ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -77.86 -67.02 0.77 Allowed 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.576 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.962 HG23 HG22 ' A' ' 15' ' ' THR . 93.0 t -90.83 33.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 5.9 tttm -55.14 -16.89 3.46 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.827 0.822 . . . . 0.0 110.588 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt . . . . . 0 C--N 1.289 -2.033 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.183 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 1' ' ' THR . 54.1 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.237 0.542 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.0 mt -92.85 71.09 4.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 110.203 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.07 105.42 14.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 110.182 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 7' ' ' MET . 17.6 m -126.33 165.51 27.43 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.747 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 43.0 Cg_endo -69.44 67.71 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.819 1.431 . . . . 0.0 109.919 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 12' ' ' CYS . . . 161.56 -25.78 0.25 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.67 ' HB2' HG22 ' A' ' 4' ' ' VAL . 6.5 mtt -126.99 120.69 29.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -1.122 . . . . 0.0 110.472 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 78.6 m 54.2 78.55 0.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.863 . . . . 0.0 110.779 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.904 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 13.3 p -152.99 60.48 0.78 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 0.0 110.874 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.01 27.73 0.54 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.904 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -138.61 -55.55 0.62 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.331 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.654 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.7 p -138.53 32.67 0.2 Allowed Pre-proline 0 N--CA 1.495 1.804 0 C-N-CA 119.086 -1.046 . . . . 0.0 113.048 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 41.5 Cg_endo -67.83 -16.12 45.3 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 N-CA-C 105.667 -2.474 . . . . 0.0 105.667 175.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 tp -91.67 -24.06 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 121.798 0.809 . . . . 0.0 110.303 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.855 HG22 HG23 ' A' ' 16' ' ' VAL 0.259 0.8 OUTLIER -89.49 -60.73 1.87 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.526 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.855 HG23 HG22 ' A' ' 15' ' ' THR . 70.3 t -90.46 36.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 6.7 tttt -54.5 -17.79 3.59 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.975 0.893 . . . . 0.0 110.466 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.29 -1.983 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.069 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.29 0.567 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.78 115.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.316 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.73 75.07 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 110.038 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.3 t -83.4 123.6 76.67 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 110.059 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.67 107.29 2.15 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.884 1.465 . . . . 0.0 110.348 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 7' ' ' MET . . . 126.0 -27.99 4.98 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.526 ' HB2' HG21 ' A' ' 16' ' ' VAL . 48.2 mmm 60.58 -138.77 0.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -1.12 . . . . 0.0 109.827 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 7' ' ' MET . 23.9 m 60.66 76.67 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.354 -0.842 . . . . 0.0 109.642 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.479 ' C ' ' N ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -148.14 47.04 1.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.43 -0.794 . . . . 0.0 109.525 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 47.22 27.02 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.496 ' H ' ' HD3' ' A' ' 13' ' ' PRO . . . -138.48 -53.43 0.61 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.425 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.67 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -129.55 27.92 0.15 Allowed Pre-proline 0 N--CA 1.498 1.965 0 C-N-CA 119.179 -1.009 . . . . 0.0 112.92 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 40.5 Cg_endo -67.5 -14.61 42.9 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 N-CA-C 105.891 -2.388 . . . . 0.0 105.891 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.478 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -90.88 -23.77 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 121.691 0.757 . . . . 0.0 110.302 179.276 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.906 HG22 HG13 ' A' ' 16' ' ' VAL 0.263 1.0 OUTLIER -70.38 -64.56 0.87 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.589 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.906 HG13 HG22 ' A' ' 15' ' ' THR . 32.2 m -90.82 32.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.478 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -48.92 -23.02 0.96 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 122.144 0.973 . . . . 0.0 110.219 -179.033 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.287 -2.125 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.258 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 1' ' ' THR . 2.2 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.181 0.515 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.794 ' O ' HD23 ' A' ' 2' ' ' LEU . 1.1 tt -45.41 115.23 0.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.952 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.71 177.87 4.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 110.39 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.505 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 3.4 m -98.87 166.49 13.01 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.856 . . . . 0.0 110.042 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 45.3 Cg_endo -72.92 76.36 2.52 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.921 1.485 . . . . 0.0 110.331 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.44 -119.8 1.12 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -169.42 -165.53 0.53 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.259 -1.142 . . . . 0.0 109.957 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 13' ' ' PRO . 4.2 m 49.18 97.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.07 -1.019 . . . . 0.0 110.055 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.876 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 24.5 p -162.49 64.9 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.977 . . . . 0.0 110.899 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.55 27.68 0.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.876 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -142.17 -61.71 0.45 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.441 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 13.8 p -134.49 44.55 1.22 Allowed Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.092 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 46.6 Cg_endo -74.96 -9.33 20.78 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 N-CA-C 105.656 -2.479 . . . . 0.0 105.656 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 7.5 pt -90.0 -23.62 6.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.187 0.994 . . . . 0.0 109.139 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.816 HG22 HG23 ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -73.26 -70.26 0.38 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.811 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.816 HG23 HG22 ' A' ' 15' ' ' THR . 53.5 t -90.82 31.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 5.6 tttt -52.04 -19.38 1.84 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.944 0.878 . . . . 0.0 110.519 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.4 pttp . . . . . 0 C--N 1.288 -2.07 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.22 -179.902 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.252 0.549 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.612 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 1.1 mp 56.17 -178.6 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.204 -0.935 . . . . 0.0 110.243 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 2' ' ' LEU . . . 63.18 50.78 2.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 110.434 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.501 HG23 ' HD2' ' A' ' 5' ' ' PRO . 11.4 p -143.22 142.83 22.44 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.13 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.501 ' HD2' HG23 ' A' ' 4' ' ' VAL . 47.6 Cg_endo -73.35 149.2 44.67 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.015 1.534 . . . . 0.0 110.36 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.36 -27.88 8.08 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.778 ' CB ' HG11 ' A' ' 16' ' ' VAL . 9.1 mtm 52.59 -157.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -1.166 . . . . 0.0 109.731 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.761 ' O ' HG22 ' A' ' 8' ' ' THR . 1.9 m 52.32 81.7 0.08 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.093 -1.005 . . . . 0.0 109.992 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.907 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 21.0 p -153.6 61.89 0.74 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 0.0 111.028 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.03 28.64 0.65 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.907 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -141.61 -53.83 0.45 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.377 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 8.6 p -141.44 37.41 0.26 Allowed Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.857 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.4 Cg_endo -69.77 -12.89 33.8 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 105.83 -2.411 . . . . 0.0 105.83 175.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 2.0 tp -87.65 -22.3 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 122.002 0.906 . . . . 0.0 109.455 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.601 HG22 ' N ' ' A' ' 16' ' ' VAL 0.273 0.9 OUTLIER -83.75 -59.56 2.39 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.322 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.778 HG11 ' CB ' ' A' ' 7' ' ' MET . 14.7 p -90.93 37.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.468 ' CA ' ' O ' ' A' ' 13' ' ' PRO . 2.8 tttt -66.09 -4.68 7.83 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.676 0.751 . . . . 0.0 111.223 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.034 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.223 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.274 0.559 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.96 36.73 4.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 0.0 110.261 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.9 100.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 110.142 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.533 HG21 ' SG ' ' A' ' 12' ' ' CYS . 27.6 m -102.59 165.8 13.1 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.831 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 40.9 Cg_endo -67.62 59.76 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.783 1.412 . . . . 0.0 109.946 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 7' ' ' MET . . . 153.72 -150.95 22.74 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.447 ' HB3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER 176.74 122.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -1.216 . . . . 0.0 109.895 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.55 ' O ' HG22 ' A' ' 8' ' ' THR . 17.6 m 44.46 83.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.111 -0.993 . . . . 0.0 110.303 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.899 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 20.8 p -157.18 62.46 0.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.961 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.16 28.01 0.61 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.899 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.56 -55.22 0.51 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.147 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.634 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 12.7 p -140.26 35.65 0.23 Allowed Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.873 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 41.5 Cg_endo -68.54 -14.61 40.07 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 N-CA-C 105.703 -2.46 . . . . 0.0 105.703 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 tp -90.5 -25.48 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-O 122.04 0.924 . . . . 0.0 109.314 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 1.016 HG22 HG23 ' A' ' 16' ' ' VAL 0.264 0.8 OUTLIER -91.3 -63.22 1.29 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.272 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.016 HG23 HG22 ' A' ' 15' ' ' THR . 58.2 t -90.2 37.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -56.03 -16.51 5.05 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.881 0.848 . . . . 0.0 110.476 -179.288 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.4 tptm . . . . . 0 C--N 1.289 -2.027 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.189 179.809 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.249 0.547 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.6 mt -128.33 133.29 48.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 110.217 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.21 108.94 2.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.2 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.463 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 23.2 m -57.7 163.77 3.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.218 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 45.9 Cg_endo -73.1 123.07 8.57 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.974 1.512 . . . . 0.0 110.456 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 7' ' ' MET . . . 115.96 -27.23 8.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.962 ' HG2' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER 56.31 -156.92 0.27 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -1.101 . . . . 0.0 109.991 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.723 ' O ' HG22 ' A' ' 8' ' ' THR . 3.4 m 55.09 78.55 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.103 -0.998 . . . . 0.0 110.038 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.908 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 19.4 p -147.72 61.93 1.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.7 27.94 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.908 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.99 -59.15 0.5 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.815 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.64 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.0 p -134.58 35.47 0.28 Allowed Pre-proline 0 N--CA 1.496 1.849 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.844 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.2 Cg_endo -69.43 -12.46 33.56 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 N-CA-C 105.913 -2.38 . . . . 0.0 105.913 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.7 pt -90.66 -22.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 122.041 0.924 . . . . 0.0 109.509 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.872 HG22 HG23 ' A' ' 16' ' ' VAL 0.266 0.8 OUTLIER -88.92 -63.47 1.29 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.112 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.962 HG21 ' HG2' ' A' ' 7' ' ' MET . 76.0 t -90.27 40.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 23.7 tttm -66.53 -5.81 12.68 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.638 0.733 . . . . 0.0 110.864 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.289 -2.032 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.275 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.727 ' O ' HG22 ' A' ' 8' ' ' THR . 17.7 m . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 121.148 0.499 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.927 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 22.5 p -146.58 60.81 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.98 -1.075 . . . . 0.0 110.989 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.32 28.53 0.72 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.927 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -141.79 -55.8 0.46 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.597 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.654 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 7.9 p -137.26 32.61 0.2 Allowed Pre-proline 0 N--CA 1.496 1.852 0 C-N-CA 119.035 -1.066 . . . . 0.0 113.107 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 40.6 Cg_endo -67.55 -13.84 40.33 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 N-CA-C 105.967 -2.359 . . . . 0.0 105.967 175.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.545 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -89.22 -20.89 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 121.874 0.845 . . . . 0.0 109.753 179.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.673 HG22 ' N ' ' A' ' 16' ' ' VAL 0.268 0.9 OUTLIER -76.97 -67.1 0.74 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.368 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.673 ' N ' HG22 ' A' ' 15' ' ' THR . 7.0 p -90.93 33.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.545 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 121.878 0.847 . . . . 0.0 110.748 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.706 HG23 ' HB3' ' A' ' 13' ' ' PRO . 17.8 m . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 121.248 0.547 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.904 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 14.0 p -146.89 62.13 1.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.2 -0.937 . . . . 0.0 110.704 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 47.24 27.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.904 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -141.39 -58.77 0.49 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.763 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.652 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.2 p -134.25 32.44 0.22 Allowed Pre-proline 0 N--CA 1.495 1.817 0 C-N-CA 118.92 -1.112 . . . . 0.0 113.395 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.706 ' HB3' HG23 ' A' ' 8' ' ' THR . 42.3 Cg_endo -69.09 -14.7 38.71 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 N-CA-C 105.57 -2.511 . . . . 0.0 105.57 175.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -20.65 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 121.899 0.857 . . . . 0.0 109.56 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 1.0 HG22 HG23 ' A' ' 16' ' ' VAL 0.261 0.6 OUTLIER -88.46 -58.84 2.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.742 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.0 HG23 HG22 ' A' ' 15' ' ' THR . 43.1 t -91.08 31.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 8.0 pttt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.75 0.786 . . . . 0.0 110.979 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.692 ' O ' HG22 ' A' ' 8' ' ' THR . 8.3 m . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 121.181 0.515 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.92 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 18.8 p -145.67 60.97 1.27 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.113 -0.992 . . . . 0.0 110.768 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.44 28.15 0.7 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.92 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.79 -60.03 0.51 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.807 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.658 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 10.2 p -130.73 30.8 0.2 Allowed Pre-proline 0 N--CA 1.497 1.885 0 C-N-CA 119.054 -1.058 . . . . 0.0 113.238 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 39.4 Cg_endo -67.28 -14.96 44.75 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 N-CA-C 105.718 -2.455 . . . . 0.0 105.718 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.455 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -85.33 -20.72 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 121.895 0.855 . . . . 0.0 109.54 178.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.839 HG22 HG23 ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -84.91 -59.64 2.28 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.336 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.839 HG23 HG22 ' A' ' 15' ' ' THR . 4.2 t -91.14 36.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 17' ' ' LYS . 3.1 tmtm? . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.798 0.809 . . . . 0.0 110.979 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.179 0.514 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.944 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 24.3 p -169.17 58.43 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.988 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.08 28.35 0.63 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.944 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.66 -55.88 0.51 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.665 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.64 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 7.3 p -137.53 34.86 0.24 Allowed Pre-proline 0 N--CA 1.496 1.83 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.995 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.7 Cg_endo -70.03 -13.23 33.75 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 N-CA-C 105.741 -2.446 . . . . 0.0 105.741 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.48 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.1 tt -90.28 -21.98 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.825 0.821 . . . . 0.0 109.742 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.962 HG22 HG23 ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -77.86 -67.02 0.77 Allowed 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.576 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.962 HG23 HG22 ' A' ' 15' ' ' THR . 93.0 t -90.83 33.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 5.9 tttm . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.827 0.822 . . . . 0.0 110.588 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 78.6 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.137 0.494 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.904 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 13.3 p -152.99 60.48 0.78 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 0.0 110.874 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.01 27.73 0.54 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.904 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -138.61 -55.55 0.62 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.331 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.654 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.7 p -138.53 32.67 0.2 Allowed Pre-proline 0 N--CA 1.495 1.804 0 C-N-CA 119.086 -1.046 . . . . 0.0 113.048 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 41.5 Cg_endo -67.83 -16.12 45.3 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 N-CA-C 105.667 -2.474 . . . . 0.0 105.667 175.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 tp -91.67 -24.06 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 121.798 0.809 . . . . 0.0 110.303 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.855 HG22 HG23 ' A' ' 16' ' ' VAL 0.259 0.8 OUTLIER -89.49 -60.73 1.87 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.526 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.855 HG23 HG22 ' A' ' 15' ' ' THR . 70.3 t -90.46 36.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 tttt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.975 0.893 . . . . 0.0 110.466 -179.236 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.411 ' C ' ' SG ' ' A' ' 9' ' ' CYS . 23.9 m . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.394 0.616 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.479 ' C ' ' N ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -148.14 47.04 1.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.43 -0.794 . . . . 0.0 109.525 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 47.22 27.02 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.496 ' H ' ' HD3' ' A' ' 13' ' ' PRO . . . -138.48 -53.43 0.61 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.425 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.67 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -129.55 27.92 0.15 Allowed Pre-proline 0 N--CA 1.498 1.965 0 C-N-CA 119.179 -1.009 . . . . 0.0 112.92 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 40.5 Cg_endo -67.5 -14.61 42.9 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 N-CA-C 105.891 -2.388 . . . . 0.0 105.891 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.478 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -90.88 -23.77 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 121.691 0.757 . . . . 0.0 110.302 179.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.906 HG22 HG13 ' A' ' 16' ' ' VAL 0.263 1.0 OUTLIER -70.38 -64.56 0.87 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.589 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.906 HG13 HG22 ' A' ' 15' ' ' THR . 32.2 m -90.82 32.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.478 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 122.144 0.973 . . . . 0.0 110.219 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 13' ' ' PRO . 4.2 m . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.222 0.534 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.876 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 24.5 p -162.49 64.9 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.977 . . . . 0.0 110.899 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.55 27.68 0.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.876 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -142.17 -61.71 0.45 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.441 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 13.8 p -134.49 44.55 1.22 Allowed Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.092 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 46.6 Cg_endo -74.96 -9.33 20.78 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 N-CA-C 105.656 -2.479 . . . . 0.0 105.656 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 7.5 pt -90.0 -23.62 6.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.187 0.994 . . . . 0.0 109.139 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.816 HG22 HG23 ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -73.26 -70.26 0.38 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.811 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.816 HG23 HG22 ' A' ' 15' ' ' THR . 53.5 t -90.82 31.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 5.6 tttt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.944 0.878 . . . . 0.0 110.519 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.761 ' O ' HG22 ' A' ' 8' ' ' THR . 1.9 m . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.068 0.461 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.907 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 21.0 p -153.6 61.89 0.74 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 0.0 111.028 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.03 28.64 0.65 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.907 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -141.61 -53.83 0.45 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.377 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 8.6 p -141.44 37.41 0.26 Allowed Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.857 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.4 Cg_endo -69.77 -12.89 33.8 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 105.83 -2.411 . . . . 0.0 105.83 175.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 2.0 tp -87.65 -22.3 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 122.002 0.906 . . . . 0.0 109.455 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.601 HG22 ' N ' ' A' ' 16' ' ' VAL 0.273 0.9 OUTLIER -83.75 -59.56 2.39 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.322 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.601 ' N ' HG22 ' A' ' 15' ' ' THR . 14.7 p -90.93 37.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.468 ' CA ' ' O ' ' A' ' 13' ' ' PRO . 2.8 tttt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 121.676 0.751 . . . . 0.0 111.223 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.55 ' O ' HG22 ' A' ' 8' ' ' THR . 17.6 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.155 0.502 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.899 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 20.8 p -157.18 62.46 0.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.961 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.16 28.01 0.61 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.899 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.56 -55.22 0.51 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.147 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.634 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 12.7 p -140.26 35.65 0.23 Allowed Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.873 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 41.5 Cg_endo -68.54 -14.61 40.07 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 N-CA-C 105.703 -2.46 . . . . 0.0 105.703 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 tp -90.5 -25.48 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-O 122.04 0.924 . . . . 0.0 109.314 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 1.016 HG22 HG23 ' A' ' 16' ' ' VAL 0.264 0.8 OUTLIER -91.3 -63.22 1.29 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.272 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.016 HG23 HG22 ' A' ' 15' ' ' THR . 58.2 t -90.2 37.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.881 0.848 . . . . 0.0 110.476 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.723 ' O ' HG22 ' A' ' 8' ' ' THR . 3.4 m . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.168 0.508 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.908 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 19.4 p -147.72 61.93 1.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.7 27.94 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.908 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.99 -59.15 0.5 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.815 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.64 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.0 p -134.58 35.47 0.28 Allowed Pre-proline 0 N--CA 1.496 1.849 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.844 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.2 Cg_endo -69.43 -12.46 33.56 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 N-CA-C 105.913 -2.38 . . . . 0.0 105.913 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.7 pt -90.66 -22.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 122.041 0.924 . . . . 0.0 109.509 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.872 HG22 HG23 ' A' ' 16' ' ' VAL 0.266 0.8 OUTLIER -88.92 -63.47 1.29 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.112 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.872 HG23 HG22 ' A' ' 15' ' ' THR . 76.0 t -90.27 40.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 23.7 tttm . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.638 0.733 . . . . 0.0 110.864 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 1' ' ' THR . 8.9 t . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.239 0.542 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 56.4 mt 50.65 -141.86 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 110.131 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.72 152.92 11.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 110.29 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.496 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 25.4 m -140.79 166.26 24.03 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.825 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 43.4 Cg_endo -70.26 85.3 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.803 1.423 . . . . 0.0 110.384 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 7' ' ' MET . . . 154.9 -60.31 0.38 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.577 ' CB ' HG11 ' A' ' 16' ' ' VAL . 0.6 OUTLIER 56.55 -161.89 0.19 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.339 -1.095 . . . . 0.0 109.894 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.727 ' O ' HG22 ' A' ' 8' ' ' THR . 17.7 m 54.1 69.76 0.68 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.18 -0.95 . . . . 0.0 110.267 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.927 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 22.5 p -146.58 60.81 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.98 -1.075 . . . . 0.0 110.989 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.32 28.53 0.72 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.927 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -141.79 -55.8 0.46 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.597 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.654 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 7.9 p -137.26 32.61 0.2 Allowed Pre-proline 0 N--CA 1.496 1.852 0 C-N-CA 119.035 -1.066 . . . . 0.0 113.107 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 40.6 Cg_endo -67.55 -13.84 40.33 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 N-CA-C 105.967 -2.359 . . . . 0.0 105.967 175.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.545 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -89.22 -20.89 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 121.874 0.845 . . . . 0.0 109.753 179.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.673 HG22 ' N ' ' A' ' 16' ' ' VAL 0.268 0.9 OUTLIER -76.97 -67.1 0.74 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.368 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.673 ' N ' HG22 ' A' ' 15' ' ' THR . 7.0 p -90.93 33.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.545 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -56.58 -15.03 3.66 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.878 0.847 . . . . 0.0 110.748 -179.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.2 tptp . . . . . 0 C--N 1.29 -1.993 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.163 179.979 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.309 0.576 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 mp -119.73 38.08 4.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.212 -0.93 . . . . 0.0 110.248 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.1 117.18 31.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.044 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.4 t -94.83 133.08 27.11 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.967 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.74 120.83 7.38 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.95 1.5 . . . . 0.0 110.616 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' MET . . . 119.28 -31.44 5.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.664 ' SD ' HG21 ' A' ' 16' ' ' VAL . 3.2 mmt 46.28 -159.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -1.178 . . . . 0.0 109.155 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.706 HG23 ' HB3' ' A' ' 13' ' ' PRO . 17.8 m 53.98 82.25 0.09 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.885 -1.134 . . . . 0.0 109.732 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.904 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 14.0 p -146.89 62.13 1.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.2 -0.937 . . . . 0.0 110.704 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 47.24 27.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.904 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -141.39 -58.77 0.49 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.763 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.652 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.2 p -134.25 32.44 0.22 Allowed Pre-proline 0 N--CA 1.495 1.817 0 C-N-CA 118.92 -1.112 . . . . 0.0 113.395 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.706 ' HB3' HG23 ' A' ' 8' ' ' THR . 42.3 Cg_endo -69.09 -14.7 38.71 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 N-CA-C 105.57 -2.511 . . . . 0.0 105.57 175.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -90.91 -20.65 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 121.899 0.857 . . . . 0.0 109.56 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 1.0 HG22 HG23 ' A' ' 16' ' ' VAL 0.261 0.6 OUTLIER -88.46 -58.84 2.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.742 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.0 HG23 HG22 ' A' ' 15' ' ' THR . 43.1 t -91.08 31.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 8.0 pttt -56.34 -14.77 3.16 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.75 0.786 . . . . 0.0 110.979 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.29 -2.011 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.058 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.227 0.537 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.8 81.01 1.36 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.254 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.87 142.67 6.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.264 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 4' ' ' VAL . 12.4 p -58.66 135.84 86.36 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 110.005 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.24 115.26 4.25 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.967 1.509 . . . . 0.0 110.364 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.42 -29.47 7.58 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.528 ' CG ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER 51.53 -164.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -1.155 . . . . 0.0 109.54 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.692 ' O ' HG22 ' A' ' 8' ' ' THR . 8.3 m 54.07 75.33 0.28 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.128 -0.982 . . . . 0.0 110.049 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.92 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 18.8 p -145.67 60.97 1.27 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.113 -0.992 . . . . 0.0 110.768 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.44 28.15 0.7 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.92 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.79 -60.03 0.51 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.807 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.658 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 10.2 p -130.73 30.8 0.2 Allowed Pre-proline 0 N--CA 1.497 1.885 0 C-N-CA 119.054 -1.058 . . . . 0.0 113.238 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 39.4 Cg_endo -67.28 -14.96 44.75 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 N-CA-C 105.718 -2.455 . . . . 0.0 105.718 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.455 HG22 ' H ' ' A' ' 14' ' ' ILE . 0.3 OUTLIER -85.33 -20.72 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 121.895 0.855 . . . . 0.0 109.54 178.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.839 HG22 HG23 ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -84.91 -59.64 2.28 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.336 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.839 HG23 HG22 ' A' ' 15' ' ' THR . 4.2 t -91.14 36.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 17' ' ' LYS . 3.1 tmtm? -59.84 -11.51 5.56 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.798 0.809 . . . . 0.0 110.979 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 mptt . . . . . 0 C--N 1.284 -2.249 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.322 179.744 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.201 0.524 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.581 ' O ' HG23 ' A' ' 15' ' ' THR . 0.1 OUTLIER -52.54 -37.82 58.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.942 . . . . 0.0 110.01 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.71 132.49 52.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.317 -0.864 . . . . 0.0 109.982 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.538 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 2.7 m -124.38 168.32 13.33 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.3 -0.875 . . . . 0.0 109.743 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.538 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 41.2 Cg_endo -68.35 65.94 1.09 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.741 1.39 . . . . 0.0 109.721 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 4' ' ' VAL . . . 144.66 174.74 17.19 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.487 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -146.88 127.64 14.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.076 -1.249 . . . . 0.0 110.383 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 m 53.03 92.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.396 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.944 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 24.3 p -169.17 58.43 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.988 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.08 28.35 0.63 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.944 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.66 -55.88 0.51 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.665 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.64 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 7.3 p -137.53 34.86 0.24 Allowed Pre-proline 0 N--CA 1.496 1.83 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.995 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.7 Cg_endo -70.03 -13.23 33.75 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 N-CA-C 105.741 -2.446 . . . . 0.0 105.741 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.48 HG22 ' H ' ' A' ' 14' ' ' ILE . 1.1 tt -90.28 -21.98 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.825 0.821 . . . . 0.0 109.742 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.962 HG22 HG23 ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -77.86 -67.02 0.77 Allowed 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.576 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.962 HG23 HG22 ' A' ' 15' ' ' THR . 93.0 t -90.83 33.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 5.9 tttm -55.14 -16.89 3.46 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.827 0.822 . . . . 0.0 110.588 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt . . . . . 0 C--N 1.289 -2.033 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.183 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.447 ' O ' HG22 ' A' ' 1' ' ' THR . 54.1 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.237 0.542 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.0 mt -92.85 71.09 4.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 110.203 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.07 105.42 14.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 110.182 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 7' ' ' MET . 17.6 m -126.33 165.51 27.43 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.747 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 43.0 Cg_endo -69.44 67.71 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.819 1.431 . . . . 0.0 109.919 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 12' ' ' CYS . . . 161.56 -25.78 0.25 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.67 ' HB2' HG22 ' A' ' 4' ' ' VAL . 6.5 mtt -126.99 120.69 29.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -1.122 . . . . 0.0 110.472 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 78.6 m 54.2 78.55 0.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.863 . . . . 0.0 110.779 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.904 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 13.3 p -152.99 60.48 0.78 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 0.0 110.874 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.01 27.73 0.54 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.904 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -138.61 -55.55 0.62 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.331 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.654 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.7 p -138.53 32.67 0.2 Allowed Pre-proline 0 N--CA 1.495 1.804 0 C-N-CA 119.086 -1.046 . . . . 0.0 113.048 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 41.5 Cg_endo -67.83 -16.12 45.3 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 N-CA-C 105.667 -2.474 . . . . 0.0 105.667 175.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 tp -91.67 -24.06 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 121.798 0.809 . . . . 0.0 110.303 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.855 HG22 HG23 ' A' ' 16' ' ' VAL 0.259 0.8 OUTLIER -89.49 -60.73 1.87 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.526 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.855 HG23 HG22 ' A' ' 15' ' ' THR . 70.3 t -90.46 36.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 6.7 tttt -54.5 -17.79 3.59 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.975 0.893 . . . . 0.0 110.466 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.29 -1.983 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.069 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.29 0.567 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.78 115.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.316 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.73 75.07 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 110.038 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.3 t -83.4 123.6 76.67 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 110.059 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.67 107.29 2.15 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.884 1.465 . . . . 0.0 110.348 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 7' ' ' MET . . . 126.0 -27.99 4.98 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.526 ' HB2' HG21 ' A' ' 16' ' ' VAL . 48.2 mmm 60.58 -138.77 0.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.296 -1.12 . . . . 0.0 109.827 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 7' ' ' MET . 23.9 m 60.66 76.67 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.354 -0.842 . . . . 0.0 109.642 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.479 ' C ' ' N ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -148.14 47.04 1.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.43 -0.794 . . . . 0.0 109.525 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 47.22 27.02 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.496 ' H ' ' HD3' ' A' ' 13' ' ' PRO . . . -138.48 -53.43 0.61 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.425 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.67 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -129.55 27.92 0.15 Allowed Pre-proline 0 N--CA 1.498 1.965 0 C-N-CA 119.179 -1.009 . . . . 0.0 112.92 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 40.5 Cg_endo -67.5 -14.61 42.9 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 N-CA-C 105.891 -2.388 . . . . 0.0 105.891 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.478 ' HA ' ' HB3' ' A' ' 17' ' ' LYS . 0.9 OUTLIER -90.88 -23.77 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 121.691 0.757 . . . . 0.0 110.302 179.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.906 HG22 HG13 ' A' ' 16' ' ' VAL 0.263 1.0 OUTLIER -70.38 -64.56 0.87 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.589 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.906 HG13 HG22 ' A' ' 15' ' ' THR . 32.2 m -90.82 32.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.478 ' HB3' ' HA ' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -48.92 -23.02 0.96 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 122.144 0.973 . . . . 0.0 110.219 -179.033 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.287 -2.125 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.258 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 1' ' ' THR . 2.2 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.181 0.515 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.794 ' O ' HD23 ' A' ' 2' ' ' LEU . 1.1 tt -45.41 115.23 0.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.952 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.71 177.87 4.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 110.39 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.505 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 3.4 m -98.87 166.49 13.01 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.856 . . . . 0.0 110.042 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 45.3 Cg_endo -72.92 76.36 2.52 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.921 1.485 . . . . 0.0 110.331 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.44 -119.8 1.12 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -169.42 -165.53 0.53 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.259 -1.142 . . . . 0.0 109.957 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 13' ' ' PRO . 4.2 m 49.18 97.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.07 -1.019 . . . . 0.0 110.055 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.876 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 24.5 p -162.49 64.9 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.977 . . . . 0.0 110.899 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.55 27.68 0.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.876 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -142.17 -61.71 0.45 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.441 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 13.8 p -134.49 44.55 1.22 Allowed Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.092 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 46.6 Cg_endo -74.96 -9.33 20.78 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 N-CA-C 105.656 -2.479 . . . . 0.0 105.656 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 7.5 pt -90.0 -23.62 6.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.187 0.994 . . . . 0.0 109.139 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.816 HG22 HG23 ' A' ' 16' ' ' VAL 0.269 0.9 OUTLIER -73.26 -70.26 0.38 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.811 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.816 HG23 HG22 ' A' ' 15' ' ' THR . 53.5 t -90.82 31.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 5.6 tttt -52.04 -19.38 1.84 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.944 0.878 . . . . 0.0 110.519 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.4 pttp . . . . . 0 C--N 1.288 -2.07 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.22 -179.902 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.252 0.549 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.612 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 1.1 mp 56.17 -178.6 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.204 -0.935 . . . . 0.0 110.243 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 2' ' ' LEU . . . 63.18 50.78 2.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 110.434 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.501 HG23 ' HD2' ' A' ' 5' ' ' PRO . 11.4 p -143.22 142.83 22.44 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 110.13 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.501 ' HD2' HG23 ' A' ' 4' ' ' VAL . 47.6 Cg_endo -73.35 149.2 44.67 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.015 1.534 . . . . 0.0 110.36 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.36 -27.88 8.08 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.778 ' CB ' HG11 ' A' ' 16' ' ' VAL . 9.1 mtm 52.59 -157.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -1.166 . . . . 0.0 109.731 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.761 ' O ' HG22 ' A' ' 8' ' ' THR . 1.9 m 52.32 81.7 0.08 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.093 -1.005 . . . . 0.0 109.992 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.907 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 21.0 p -153.6 61.89 0.74 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 0.0 111.028 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.03 28.64 0.65 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.907 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -141.61 -53.83 0.45 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.377 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 8.6 p -141.44 37.41 0.26 Allowed Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.085 -1.046 . . . . 0.0 112.857 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.4 Cg_endo -69.77 -12.89 33.8 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 N-CA-C 105.83 -2.411 . . . . 0.0 105.83 175.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 2.0 tp -87.65 -22.3 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 122.002 0.906 . . . . 0.0 109.455 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.601 HG22 ' N ' ' A' ' 16' ' ' VAL 0.273 0.9 OUTLIER -83.75 -59.56 2.39 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.322 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.778 HG11 ' CB ' ' A' ' 7' ' ' MET . 14.7 p -90.93 37.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.468 ' CA ' ' O ' ' A' ' 13' ' ' PRO . 2.8 tttt -66.09 -4.68 7.83 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.676 0.751 . . . . 0.0 111.223 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.034 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.223 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.274 0.559 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.96 36.73 4.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 0.0 110.261 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.9 100.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 110.142 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.533 HG21 ' SG ' ' A' ' 12' ' ' CYS . 27.6 m -102.59 165.8 13.1 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.831 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 40.9 Cg_endo -67.62 59.76 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.783 1.412 . . . . 0.0 109.946 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 7' ' ' MET . . . 153.72 -150.95 22.74 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.447 ' HB3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER 176.74 122.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -1.216 . . . . 0.0 109.895 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.55 ' O ' HG22 ' A' ' 8' ' ' THR . 17.6 m 44.46 83.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.111 -0.993 . . . . 0.0 110.303 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.899 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 20.8 p -157.18 62.46 0.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.961 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.16 28.01 0.61 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.899 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.56 -55.22 0.51 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.147 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.634 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 12.7 p -140.26 35.65 0.23 Allowed Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.873 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 41.5 Cg_endo -68.54 -14.61 40.07 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 N-CA-C 105.703 -2.46 . . . . 0.0 105.703 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 tp -90.5 -25.48 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-O 122.04 0.924 . . . . 0.0 109.314 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 1.016 HG22 HG23 ' A' ' 16' ' ' VAL 0.264 0.8 OUTLIER -91.3 -63.22 1.29 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.272 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.016 HG23 HG22 ' A' ' 15' ' ' THR . 58.2 t -90.2 37.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -56.03 -16.51 5.05 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.881 0.848 . . . . 0.0 110.476 -179.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.4 tptm . . . . . 0 C--N 1.289 -2.027 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.189 179.809 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.249 0.547 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.6 mt -128.33 133.29 48.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 110.217 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.21 108.94 2.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.2 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.463 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 23.2 m -57.7 163.77 3.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.218 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 4' ' ' VAL . 45.9 Cg_endo -73.1 123.07 8.57 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.974 1.512 . . . . 0.0 110.456 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 7' ' ' MET . . . 115.96 -27.23 8.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.962 ' HG2' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER 56.31 -156.92 0.27 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -1.101 . . . . 0.0 109.991 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.723 ' O ' HG22 ' A' ' 8' ' ' THR . 3.4 m 55.09 78.55 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.103 -0.998 . . . . 0.0 110.038 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.908 ' SG ' ' HB3' ' A' ' 11' ' ' ALA . 19.4 p -147.72 61.93 1.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' CYS . . . 46.7 27.94 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.908 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -140.99 -59.15 0.5 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.815 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.64 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 11.0 p -134.58 35.47 0.28 Allowed Pre-proline 0 N--CA 1.496 1.849 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.844 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 12' ' ' CYS . 42.2 Cg_endo -69.43 -12.46 33.56 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 N-CA-C 105.913 -2.38 . . . . 0.0 105.913 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.7 pt -90.66 -22.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 122.041 0.924 . . . . 0.0 109.509 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.872 HG22 HG23 ' A' ' 16' ' ' VAL 0.266 0.8 OUTLIER -88.92 -63.47 1.29 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.112 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.962 HG21 ' HG2' ' A' ' 7' ' ' MET . 76.0 t -90.27 40.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 23.7 tttm -66.53 -5.81 12.68 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.638 0.733 . . . . 0.0 110.864 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.289 -2.032 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.275 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ' HG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_